Literature DB >> 207880

Nonsteroidal antiestrogens: their biological effects and potential mechanisms of action.

V C Jordan, C J Dix, K E Naylor, G Prestwich, L Rowsby.   

Abstract

The uterotropic and antiuterotrapic effects of a variety of structural derivatives of the nonsteroidal antiestrogen tamoxifen have been determined in the rat and the mouse. One derivative, monohydroxytamoxifen, was found to be a potent antiestrogen in the rat, with a high affinity for the estrogen receptor. Various techniques of sucrose density gradient analysis were used to demonstrate that estradiol and tamoxifen bind to the rat uterine cytoplasmic estrogen receptor. Estrogens and antiestrogens provoke the translocation of estrogen receptors to the nucleus and deplete the cytoplasmic estrogen receptor pool for short or long periods depending on the dose administered. Estradiol stimulates endometrial hyperplasia with an increase in total uterine DNA content, whereas tamoxifen stimulates endometrial hypertrophy with only a slight increase in uterine DNA content. It is concluded that the molecular shape of the ligand that binds to the estrogen receptor determines antiestrogenic activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207880     DOI: 10.1080/15287397809529666

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  15 in total

1.  The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.

Authors:  V Craig Jordan; Ifeyinwa Obiorah; Ping Fan; Helen R Kim; Eric Ariazi; Heather Cunliffe; Hiltrud Brauch
Journal:  Breast       Date:  2011-10       Impact factor: 4.380

2.  Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy.

Authors:  V Craig Jordan
Journal:  J Natl Cancer Inst       Date:  2014-09-30       Impact factor: 13.506

Review 3.  Long-term adjuvant tamoxifen therapy for breast cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

4.  Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.

Authors:  Philipp Y Maximov; Russell E McDaniel; Daphne J Fernandes; Puspanjali Bhatta; Valeriy R Korostyshevskiy; Ramona F Curpan; V Craig Jordan
Journal:  J Natl Cancer Inst       Date:  2014-09-24       Impact factor: 13.506

5.  A new triphenylethylene compound, Fc-1157a. I. Hormonal effects.

Authors:  S Kallio; L Kangas; G Blanco; R Johansson; A Karjalainen; M Perilä; I Pippo; H Sundquist; M Södervall; R Toivola
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  The effect of a single dose of oestradiol on tamoxifen-induced uterine hyperaemia and growth in the rat.

Authors:  K Marshall; J Senior
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

Review 7.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

8.  A study on the effect of a single dose of tamoxifen on uterine hyperaemia and growth in the rat.

Authors:  K Marshall; J Senior
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

Review 9.  Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  Enclomiphene induces luteolysis in the nonpregnant guinea pig.

Authors:  P K Westfahl
Journal:  Experientia       Date:  1989-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.